fig1

Figure 1. Experimental design: model of L-arginine-induced acute pancreatitis. Schematic representation showing distribution of the study groups: (A) Control group, injected with saline buffer (in blue); (B) Acute pancreatitis group, injected with L-arginine (in yellow); (C) Acute pancreatitis with PgNVs treatment 2 h before L-arginine administration. AP: Acute pancreatitis; PgNVs: pomegranate-derived nanovesicles.